High dose chemoradiotherapy and Asct may overcome the prognostic importance of biologic markers in relapsed/refractory hodgkin lymphoma

Daniel O. Persky, Craig Moskowitz, Alexander Filatov, Rakhee Saxena, Haiyan Cui, Julie Teruya-Feldstein

Research output: Contribution to journalArticle

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)35-40
Number of pages6
JournalApplied Immunohistochemistry and Molecular Morphology
Issue number1
StatePublished - Jan 1 2010
Externally publishedYes



  • Autologous stem cell transplant (ASCT)
  • Biomarkers
  • Chemoradiotherapy
  • Relapsed/refractory Hodgkin lymphoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology
  • Histology

Cite this